BusinessAXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing GumBy Nasdaq OMXMar 7, 2017, 2:02 PM UTC
BusinessAXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing GumBy Nasdaq OMXMar 7, 2017, 2:02 PM UTC
BusinessETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.By Nasdaq OMXMar 6, 2017, 12:45 PM UTC
BusinessAXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing GumBy Nasdaq OMXMar 1, 2017, 2:01 PM UTC
BusinessAXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing GumBy Nasdaq OMXMar 1, 2017, 2:01 PM UTC
BusinessPatients Suffering From Epileptic Seizures in Brazil Have New Relief OptionsBy Nasdaq OMXFeb 28, 2017, 2:00 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessDr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at SmallCapVoice.comBy Nasdaq OMXFeb 27, 2017, 1:00 PM UTC
